Background Escitalopram is licensed for use at doses up to 20 mg but is used clinically at higher doses. There is limited published data at higher doses and none in the treatment of Major ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

Because of this definition, they have not been subject to reports of efficacy and adverse events compared with US FDA-approved hormones. The Endocrine Society, FDA and other organizations are now ...